Comparative Effects of Mechanical and Manual Airway Clearance Techniques in Cystic Fibrosis
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jul 3, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different ways to help clear the lungs in people with cystic fibrosis, a condition that causes thick mucus to build up in the lungs. The researchers want to find out which method—using a mechanical device called a flutter combined with a breathing technique (ACBT), or using traditional manual methods like postural drainage with ACBT—works better to improve breathing, reduce shortness of breath, help with sleep quality, and encourage patients to stick with their treatment.
People who might be eligible to take part are those between 16 and 40 years old who have been diagnosed with cystic fibrosis and are able to cooperate during the treatment. People with recent rib fractures, a history of heart surgery, or certain disabilities will not be able to join. Participants can expect to try both types of airway clearance techniques so the researchers can compare how well each one works for them. This study could help doctors recommend the best way to keep lungs clear and improve quality of life for people with cystic fibrosis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient having clinically diagnose Cystic fibrosis.
- • Age 16-40 year.
- • Both male and female.
- • Subjects who are conscious and cooperative .
- Exclusion Criteria:
- • Rib fracture
- • History of cardiac surgery.
- • Subject with any Physical or Mental Disability
- • Age less than 16 years
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sheikhupura, Punjab, Pakistan
Patients applied
Trial Officials
iram nawaz, mphill
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported